Status:

RECRUITING

Efficacy and Safety of a Beet-Derived Inorganic Nitrate-Based Food Product for the Prevention of Contrast-Induced Nephropathy in High-Risk Patients Undergoing Percutaneous Coronary Intervention

Lead Sponsor:

National Medical Research Center for Therapy and Preventive Medicine

Conditions:

Contrast-induced Nephropathy Following Percutaneous Intervention (CIN)

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

Contrast-induced nephropathy (CIN) is a common complication in high-risk patients undergoing percutaneous coronary intervention (PCI) due to exposure to iodinated contrast agents. CIN is associated wi...

Eligibility Criteria

Inclusion

  • Age ≥18 years.
  • Planned PCI.
  • High risk of CIN with:
  • eGFR according to the CKD-EPI formula \<60 ml/min/1.73 m2 or
  • At least two of the following criteria: liver damage (cirrhosis), diabetes mellitus, age \>70 years, administration of contrast in the last 7 days, CHF (LVEF \>40%), intake of drugs affecting renal function (ACE inhibitors, ARBs, NSAIDs, aminoglycosides, diuretics).
  • Signing informed consent.

Exclusion

  • Allergy to nitrates.
  • Acute coronary syndrome.
  • Acute condition accompanied by systolic blood pressure \<90 mmHg for more th an 30 minutes or requiring the use of drugs with a positive inotropic effect.
  • Life-threatening conditions requiring emergency medical care.
  • Participation in other clinical trials.
  • Pregnancy, lactation.
  • Use of nitrates in the last 30 days.
  • Abuse of alcohol, illegal drugs, mnestic-intellectual decline, as well as other reasons and circumstances indicating expected low adherence to treatment.
  • Refusal to follow the plan of visits and examinations provided for by the protocol of this clinical trial.
  • Refusal to sign informed consent.
  • Infectious diseases.

Key Trial Info

Start Date :

April 1 2025

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

March 1 2026

Estimated Enrollment :

88 Patients enrolled

Trial Details

Trial ID

NCT06984406

Start Date

April 1 2025

End Date

March 1 2026

Last Update

May 22 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Federal State Budgetary Institution National Medical Research Center for Therapy and Preventive Medicine of the Ministry of Healthсare of the Russian Federation

Moscow, Russia